Page last updated: 2024-11-05

zaleplon and Injuries

zaleplon has been researched along with Injuries in 1 studies

zaleplon: an azabicyclo(4.3.0)nonane; a nonbenzodiazepine; one of the so-called of Z drugs (zopiclone, eszopiclone, zolpidem, and zaleplon) for which there is some correlation with tumors; a hypnotic with less marked effect on psychomotor functions compared to lorazepam
zaleplon : A pyrazolo[1,5-a]pyrimidine having a nitrile group at position 3 and a 3-(N-ethylacetamido)phenyl substituent at the 7-position.

Injuries: Used with anatomic headings, animals, and sports for wounds and injuries. Excludes cell damage, for which pathology is used.

Research Excerpts

ExcerptRelevanceReference
"To identify and analyze postmarketing cases of complex sleep behaviors (CSBs) resulting in serious injuries, including death, associated with eszopiclone, zaleplon, or zolpidem (Z-drugs)."9.05Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. ( Chan, V; Croteau, D; Harbourt, K; Nevo, ON; Zhang, R, 2020)
"To identify and analyze postmarketing cases of complex sleep behaviors (CSBs) resulting in serious injuries, including death, associated with eszopiclone, zaleplon, or zolpidem (Z-drugs)."5.05Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death. ( Chan, V; Croteau, D; Harbourt, K; Nevo, ON; Zhang, R, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Harbourt, K1
Nevo, ON1
Zhang, R1
Chan, V1
Croteau, D1

Reviews

1 review available for zaleplon and Injuries

ArticleYear
Association of eszopiclone, zaleplon, or zolpidem with complex sleep behaviors resulting in serious injuries, including death.
    Pharmacoepidemiology and drug safety, 2020, Volume: 29, Issue:6

    Topics: Acetamides; Adult; Adverse Drug Reaction Reporting Systems; Aged; Drug Labeling; Eszopiclone; Female

2020